Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease

Table 1 Selected cohorts, their number of participants per disease stage, and their number of considered variables

Cohort	Consortium	CU	MCI	AD	Total	Number of CSF, PET, and imaging biomarkers	Number of cognitive tests
ADNI [17]	The Alzheimer’s Disease Neuroimaging Initiative	38	63	35	136	9	9
JADNI [25]	Japanese Alzheimer’s Disease Neuroimaging Initiative	17	87	10	114	9	9
AIBL [26]	The Australian Imaging, Biomarker Lifestyle Flagship Study of Ageing	92	23	13	128	0	10
NACC [27]	The National Alzheimer’s Coordinating Center	24	42	24	90	9	7
ANM [28]	AddNeuroMed	120	161	103	384	6	1
EMIF-1000 [29]	European Medical Information Framework	47	229	53	329	4	5
EDSD [30]	European DTI Study on Dementia	26	34	32	92	5	7
ARWIBO [31]	Alzheimer’s Disease Repository Without Borders	214	115	38	367	7	3
OASIS-1 [32], OASIS-2 [33]	Open Access Series of Imaging Studies	135	70	30	235	6	1
WMHAD [34]	White Matter Hyperintensities in Alzheimer’s Disease	19	27	42	88	6	7

ISSN: 1758-9193